Novo Nordisk (NYSE:NVO) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.90 by 2.22 percent. This is a 10.84 percent increase over earnings of $0.83 per share from the same period last year. The company reported quarterly sales of $10.89 billion which missed the analyst consensus estimate of $11.64 billion by 6.44 percent. This is a 14.43 percent increase over sales of $9.52 billion the same period last year.